Patent
Anti-angiogenic compositions and methods of use
Reads0
Chats0
TLDR
In this article, an anti-angiogenic factor and a polymeric carrier were used for embolization of blood vessels and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.Abstract:
The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.read more
Citations
More filters
Patent
Systems and methods for closing a hole in cardiac tissue
Ghassan S. Kassab,Jose A. Navia +1 more
TL;DR: In this article, an engagement catheter having a first and second lumen extending therethrough, an elongated wire capable of insertion into the second luminous of the engagement and a plug capable of inserting into the first lumen of the catheter, where the wire is sized for slidable insertion through the lumen and hole of the plug.
Patent
Biocompatible coatings for stents
TL;DR: In this paper, a polymer and a biologically responsive compound are used for a stent coating for a medical device, which can also contain a drug to provide an enhanced therapeutic effect.
Patent
Vascular embolic materials having multifunctions
Lee Kyu Ho,Kim Kyung Chae +1 more
TL;DR: In this article, a vascular embolic material having specific morphological, physicochemical and radiological characteristics and multifunction in the form of a bead or a sponge comprising a mixture of a hydrophilic polymer material and a metal material was presented for use in the treatment of an angiotropy of various tumors and vascular malformation.
Patent
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
TL;DR: In this article, a method for treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function using a lead-based modulating agent is provided, and screening assays for identifying pharmaceutical lead compounds capable of modulating cellular functions of Cadherin -11 such as cell proliferation, apoptosis, factor secretion, and binding of CadHERIN-11 to its counter-receptor inhibiting binding of a cell or in soluble form.
Patent
Marker delivery device for tissue marker placement
TL;DR: In this paper, a tissue marker is deployed in the lumen of a cannula, and a retraction mechanism is mounted to the handle and is configured to facilitate the complete retraction of both the cannula and the marker introducer rod into the chamber of the housing of the handle.
References
More filters
Journal ArticleDOI
The pathogenesis of atherosclerosis: a perspective for the 1990s
TL;DR: The ability to control the expression of genes encoding these molecules and to target specific cell types provides opportunities to develop new diagnostic and therapeutic agents to induce the regression of the lesions and, possibly, to prevent their formation.
Journal ArticleDOI
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
TL;DR: It is shown that vascular endothelial growth factor (VEGF) probably functions as a hypoxia-inducible angiogenic factor and is specifically induced in a subset of glioblastoma cells distinguished by their immediate proximity to necrotic foci and the clustering of capillaries alongside VEGF-producing cells.
Journal ArticleDOI
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
Patrick W. Serruys,P. de Jaegere,Ferdinand Kiemeneij,Carlos Macaya,Wolfgang Rutsch,Gr. Heyndrickx,H. Emanuelsson,Jean Marco,Victor Legrand,P. Materne +9 more
TL;DR: The clinical and angiographic outcomes were better in patients who received a stent than in those who received standard coronary angioplasty, however, this benefit was achieved at the cost of a significantly higher risk of vascular complications at the access site and a longer hospital stay.
Journal ArticleDOI
A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
David L. Fischman,Martin B. Leon,Donald S. Baim,Richard A. Schatz,Michael P. Savage,Ian M. Penn,Katherine D. Detre,Lisa Veltri,Donald R. Ricci,Masakiyo Nobuyoshi,Michael W. Cleman,Richard R. Heuser,David Almond,Paul S. Teirstein,R. David Fish,Antonio Colombo,Jeffrey C. Brinker,Jeffrey Moses,Alex Shaknovich,John N. Hirshfeld,Stephen Bailey,Stephen E. Ellis,Randal Rake,Sheldon Goldberg +23 more
TL;DR: In selected patients, placement of an intracoronary stent, as compared with balloon angioplasty, results in an improved rate of procedural success, a lower rate of angiographically detected restenosis, a similar rate of clinical events after six months, and a less frequent need for revascularization of the original coronary lesion.
Journal ArticleDOI
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
Donald R. Senger,Stephen J. Galli,Ann M. Dvorak,Carole A. Perruzzi,V. Susan Harvey,Harold F. Dvorak +5 more
TL;DR: Tumor ascites fluids from guinea pigs, hamsters, and mice contain activity that rapidly increases microvascular permeability, and this activity is secreted by these tumor cells and a variety of other tumor cell lines in vitro.